trial · primary record
Crisaborole 2% topical ointment
Psoriasis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-01-10 |
| Primary endpoint | Target Lesion Severity Score (TLSS) |
| Registry ID | NCT07892339 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:23.185Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07892339
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.